Advertisement

Share Public Profile

Public Profile URL

VITACCESS

United Kingdom

Helping biopharma generate real-world data and insights. Vitaccess combines technology and patient-centered science to deliver real-world research.

Show Articles inside

Value and Outcomes Spotlight

April 23, 2024

Pharmacological therapies for the treatment of chronic spontaneous urticaria

November 2, 2023

Vitamin D as an adjunct therapy in the treatment of atopic dermatitis: a targeted review

November 2, 2023

Feedback from prospective participants on the use of SMS surveys in real-world studies

November 2, 2023

Caregiver burden in growth hormone deficiency: a targeted review

November 2, 2023

Patient-reported severity of pain interference in Charcot-Marie-Tooth disease type 1A

October 11, 2023

How to collaborate with patients to create a real-world study

July 4, 2023

Lower extremity + upper limb disability in Charcot-Marie-Tooth disease

June 13, 2023

Patient-reported symptom severity of Charcot-Marie-Tooth disease type 1A

June 13, 2023

Patient engagement and retention in digital real-world patient-reported studies

June 6, 2023

Patient-reported impact of myasthenia gravis in the real world

May 12, 2023

Effectiveness of prostate cancer screening in reducing adult mortality: a quasi-systematic review

April 26, 2023

“Cash or credit?” Feedback from patients on the use of reward programs in digital research

April 26, 2023

Alopecia areata: targeted review of adverse events associated with clinical studies of treatments

April 26, 2023

Deprivation and access to care among patients with melanoma in the UK

November 14, 2022

Global study capturing the patient-reported impact of ALSP in the real-world setting

October 31, 2022

Challenges in presenting engagement statistics in real-world digital studies

October 20, 2022

Digital diagnosis validation feature

October 7, 2022

A review of adherence rates in real-world studies

October 7, 2022

WHITE PAPER:Patient-centric real-world evidence: benefits, uses, and the power of digital technology

October 3, 2022

Protocol for the first global study capturing the patient-reported impact of ALSP

August 31, 2022

Patient-Reported Symptom Burden of Charcot–Marie–Tooth Disease Type 1A: Findings From an Observation

August 30, 2022

Real-world patient-reported impact of myasthenia gravis: initial data from the MyRealWorld MG study

July 26, 2022

A comparison of the reimbursement of digital therapeutics in France, Germany, and the UK

July 12, 2022

Is there an optimal way to estimate healthcare resource use?

July 12, 2022

WHITE PAPER: Unleashing the potential of real-world evidence in rare diseases

July 5, 2022

Contextualizing qual. analysis w/ quant. data on symptoms & side effects in melanoma treatment in rw

July 1, 2022

Patient-reported symptom burden of Charcot-Marie-Tooth disease type 1A (CMT1A)

June 30, 2022

Depression in patients with Charcot-Marie-Tooth disease type 1A (CMT1A)

June 30, 2022

Work impacts in patients with Charcot-Marie-Tooth disease type 1A (CMT1A)

June 30, 2022

When is a patient a patient? Diagnosis validation in patient-centered research

June 28, 2022

Tips of the Trade: Delivering Patient-Centricity With Digital Real-World Evidence

June 16, 2022

Using patient-reported data to estimate costs associated with melanoma in the UK: a digital registry

June 16, 2022

Building a bridge between patient and pharma: the CMT story

June 16, 2022